The association between biochemically confirmed thyroid gland disorder and morbidity and mortality in patients with COVID‐19

Abobaker, Anis; Darrat, Milad

In sum, there is a still need for further studies to determine risks and severity of COVID-19 infection among patients with thyroid disorder. Lui D et al concluded that COVID-19 infection can lead to exacerbation of pre-existing autoimmune thyroid disease [5]. Therefore, early diagnosis and management of thyroid disorders during the pandemic time might help to reduce any potential risks and improve clinical outcome of COVID-19 infection in patients with previously undiagnosed thyroid disease. One suggested approach is to offer checking TSH level as a screening tool for individuals who are at higher risk of developing thyroid disorder, such as old age, personal history of autoimmune diseases and family history of thyroid illness [6], to increase the chance of early diagnosis and treatment of subclinical and overt thyroid disorder during this pandemic. Patients with confirmed thyroid disorder might be suitable candidates to be prioritised to receive COVID-19 vaccine to reduce risk of morbidity and mortality of COVID-19 infection. This article is protected by copyright. All rights reserved.